CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+3.15%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$3.85B
AUM Growth
-$153M
(-3.8%)
Cap. Flow
-$305M
Cap. Flow
% of AUM
-7.93%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
706
New
68
Increased
289
Reduced
229
Closed
52
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$22.9M |
| 2 |
Abbott
ABT
|
$22.2M |
| 3 |
Johnson & Johnson
JNJ
|
$21.7M |
| 4 |
Analog Devices
ADI
|
$19.2M |
| 5 |
Cummins
CMI
|
$17.1M |
Top Sells
| 1 |
Intel
INTC
|
$46M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$38.4M |
| 3 |
AbbVie
ABBV
|
$37.7M |
| 4 |
NVIDIA
NVDA
|
$24.7M |
| 5 |
Gilead Sciences
GILD
|
$22.7M |
Sector Composition
| 1 | Healthcare | 24.55% |
| 2 | Financials | 13.06% |
| 3 | Technology | 10.26% |
| 4 | Consumer Staples | 10.19% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
International Flavors & Fragrances
IFF
$16.9B
| $1.29M | 0.03% |
10,213
+4,559
| +81% | +$575K |
|
377
Zoetis
ZTS
$67.9B
| $1.28M | 0.03% |
27,049
-28,036
| -51% | -$1.33M |
|
378
Fidelity National Information Services
FIS
$35.9B
| $1.28M | 0.03% |
17,358
+10,167
| +141% | +$749K |
|
379
T Rowe Price
TROW
$23.8B
| $1.28M | 0.03% |
17,470
-2,901
| -14% | -$212K |
|
380
M&T Bank
MTB
$31.2B
| $1.27M | 0.03% |
10,739
+5,851
| +120% | +$692K |
|
381
Regency Centers
REG
$13.4B
| $1.26M | 0.03% |
15,099
-435
| -3% | -$36.4K |
|
382
TSMC
TSM
$1.26T
| $1.23M | 0.03% |
47,000
| – | – |
|
383
Mohawk Industries
MHK
$8.65B
| $1.22M | 0.03% |
6,440
+3,600
| +127% | +$683K |
|
384
MGM Resorts International
MGM
$9.98B
| $1.22M | 0.03% |
53,698
+14,802
| +38% | +$335K |
|
385
AstraZeneca
AZN
$253B
| $1.21M | 0.03% |
+40,000
| New | +$1.21M |
|
|
PXD
386
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.2M | 0.03% |
7,950
-1,186
| -13% | -$179K |
|
387
Tyson Foods
TSN
$20B
| $1.2M | 0.03% |
17,945
+3,066
| +21% | +$205K |
|
|
AVDL
388
Avadel Pharmaceuticals
AVDL
$1.53B
| $1.19M | 0.03% |
111,000
| – | – |
|
389
Boston Scientific
BSX
$159B
| $1.19M | 0.03% |
51,012
-205,076
| -80% | -$4.79M |
|
390
Globus Medical
GMED
$8.18B
| $1.19M | 0.03% |
50,000
-14,000
| -22% | -$334K |
|
391
Artivion
AORT
$2.05B
| $1.18M | 0.03% |
100,000
+14,000
| +16% | +$165K |
|
392
CME Group
CME
$94.4B
| $1.17M | 0.03% |
12,050
+2,598
| +27% | +$253K |
|
|
MACK
393
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.17M | 0.03% |
27,581
| – | – |
|
394
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $1.17M | 0.03% |
33,922
-7,579
| -18% | -$261K |
|
395
Norfolk Southern
NSC
$62.3B
| $1.17M | 0.03% |
13,696
+1,601
| +13% | +$136K |
|
|
CBIO
396
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $1.16M | 0.03% |
1,600
-499
| -24% | -$363K |
|
397
Rockwell Automation
ROK
$38.2B
| $1.16M | 0.03% |
10,111
-10
| -0.1% | -$1.15K |
|
398
Sangamo Therapeutics
SGMO
$165M
| $1.16M | 0.03% |
200,000
| – | – |
|
|
ACHN
399
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.15M | 0.03% |
148,000
-137,000
| -48% | -$1.07M |
|
400
Air Products & Chemicals
APD
$64.5B
| $1.15M | 0.03% |
8,757
+1,692
| +24% | +$222K |
|